Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes
- Haloom Rafehi
- , Antony Kaspi
- , Mark Ziemann
- , Jun Okabe
- , Tom C. Karagiannis
- , Assam El-Osta
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.